{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-25-008137","form_type":"8-K","ticker":"BGLC","cik":"0001737523","company_name":"BioNexus Gene Lab Corp","filed_at":"2025-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.282812+00:00","generated_at":"2026-05-16T20:28:42.433994+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"BioNexus files $100M shelf, enters $20M ATM with Maxim Group","bullets":["Enters Equity Distribution Agreement with Maxim Group LLC to sell up to $20M of common stock via ATM.","Filed S-3 shelf registration registering up to $100M of securities, not yet effective.","Proceeds to support growth initiatives: term sheets with Fidelion Diagnostics (VitaGuard MRD) and BirchBioMed Inc.","Company focuses on precision diagnostics, gene-based technologies in Asia and U.S."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-25-008137","json":"https://secwatch.observer/filing/0001477932-25-008137.json","markdown":"https://secwatch.observer/filing/0001477932-25-008137.md","text":"https://secwatch.observer/filing/0001477932-25-008137.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1737523/000147793225008137/0001477932-25-008137-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1737523/000147793225008137/bglc_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T20:28:42.433994+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}